Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD-Reference-Cited by-同舟云学术

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD

Published:2022-04-09 Issue:2 Volume:3 Page:
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

Li Qianqian¹²,Zhang Mengyi¹,Liang Ziteng¹³,Zhang Li¹,Wu Xi¹,Yang Chaoying¹,An Yimeng¹,Tong Jincheng¹,Liu Shuo¹,Li Tao¹,Cui Qianqian¹,Nie Jianhui¹,Wu Jiajing¹,Huang Weijin¹,Wang Youchun¹³

Affiliation:

1. Division of HIV/AIDS and Sex‐Transmitted Virus Vaccines Institute for Biological Product Control WHO Collaborating Center for Standardization and Evaluation of Biologicals NHC Key Laboratory of Research on Quality and Standardization of Biotech Products and NMPA Key Laboratory for Quality Research and Evaluation of Biological Products National Institutes for Food and Drug Control (NIFDC) Beijing China

2. Jiangsu Recbio Technology Co., Ltd. Taizhou China

3. Graduate School of Peking Union Medical College Beijing China

Funder

National Key Research and Development Program of China

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.130

Reference43 articles.